Literature DB >> 22009455

Regulation of cholesterol homeostasis.

Leigh Goedeke1, Carlos Fernández-Hernando.   

Abstract

Cholesterol homeostasis is among the most intensely regulated processes in biology. Since its isolation from gallstones at the time of the French Revolution, cholesterol has been extensively studied. Insufficient or excessive cellular cholesterol results in pathological processes including atherosclerosis and metabolic syndrome. Mammalian cells obtain cholesterol from the circulation in the form of plasma lipoproteins or intracellularly, through the synthesis of cholesterol from acetyl coenzyme A (acetyl-CoA). This process is tightly regulated at multiple levels. In this review, we provide an overview of the multiple mechanisms by which cellular cholesterol metabolism is regulated. We also discuss the recent advances in the post-transcriptional regulation of cholesterol homeostasis, including the role of small non-coding RNAs (microRNAs). These novel findings may open new avenues for the treatment of dyslipidemias and cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22009455     DOI: 10.1007/s00018-011-0857-5

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  178 in total

Review 1.  Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.

Authors:  Magdalena Jasińska; Jacek Owczarek; Daria Orszulak-Michalak
Journal:  Pharmacol Rep       Date:  2007 Sep-Oct       Impact factor: 3.024

Review 2.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

3.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

Authors:  Katey J Rayner; Frederick J Sheedy; Christine C Esau; Farah N Hussain; Ryan E Temel; Saj Parathath; Janine M van Gils; Alistair J Rayner; Aaron N Chang; Yajaira Suarez; Carlos Fernandez-Hernando; Edward A Fisher; Kathryn J Moore
Journal:  J Clin Invest       Date:  2011-06-06       Impact factor: 14.808

4.  ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions.

Authors:  Ashley M Vaughan; John F Oram
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

Review 5.  StAR protein and the regulation of steroid hormone biosynthesis.

Authors:  D M Stocco
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

6.  Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.

Authors:  J J Repa; S D Turley; J A Lobaccaro; J Medina; L Li; K Lustig; B Shan; R A Heyman; J M Dietschy; D J Mangelsdorf
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

Review 7.  Regulation of fatty acid synthesis and oxidation by the AMP-activated protein kinase.

Authors:  D G Hardie; D A Pan
Journal:  Biochem Soc Trans       Date:  2002-11       Impact factor: 5.407

8.  The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice.

Authors:  Noriko Nakanishi; Yoshimi Nakagawa; Naoko Tokushige; Naohito Aoki; Takashi Matsuzaka; Kiyoaki Ishii; Naoya Yahagi; Kazuto Kobayashi; Shigeru Yatoh; Akimitsu Takahashi; Hiroaki Suzuki; Osamu Urayama; Nobuhiro Yamada; Hitoshi Shimano
Journal:  Biochem Biophys Res Commun       Date:  2009-05-19       Impact factor: 3.575

9.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

10.  LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Authors:  Noam Zelcer; Cynthia Hong; Rima Boyadjian; Peter Tontonoz
Journal:  Science       Date:  2009-06-11       Impact factor: 47.728

View more
  49 in total

1.  Wnt directs the endosomal flux of LDL-derived cholesterol and lipid droplet homeostasis.

Authors:  Cameron C Scott; Stefania Vossio; Fabrizio Vacca; Berend Snijder; Jorge Larios; Olivier Schaad; Nicolas Guex; Dmitry Kuznetsov; Olivier Martin; Marc Chambon; Gerardo Turcatti; Lucas Pelkmans; Jean Gruenberg
Journal:  EMBO Rep       Date:  2015-04-07       Impact factor: 8.807

Review 2.  From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport.

Authors:  Alberto Dávalos; Carlos Fernández-Hernando
Journal:  Pharmacol Res       Date:  2013-02-19       Impact factor: 7.658

3.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

Review 4.  MicroRNAs: a connection between cholesterol metabolism and neurodegeneration.

Authors:  Leigh Goedeke; Carlos Fernández-Hernando
Journal:  Neurobiol Dis       Date:  2014-06-05       Impact factor: 5.996

Review 5.  MicroRNAs in brain cholesterol metabolism and their implications for Alzheimer's disease.

Authors:  Hyejin Yoon; Luis F Flores; Jungsu Kim
Journal:  Biochim Biophys Acta       Date:  2016-05-04

6.  Hepatic SREBP-2 and cholesterol biosynthesis are regulated by FoxO3 and Sirt6.

Authors:  Rongya Tao; Xiwen Xiong; Ronald A DePinho; Chu-Xia Deng; X Charlie Dong
Journal:  J Lipid Res       Date:  2013-07-23       Impact factor: 5.922

Review 7.  Cholesterol as a co-solvent and a ligand for membrane proteins.

Authors:  Yuanli Song; Anne K Kenworthy; Charles R Sanders
Journal:  Protein Sci       Date:  2013-11-18       Impact factor: 6.725

Review 8.  MicroRNAs and atherosclerosis.

Authors:  Julio Madrigal-Matute; Noemi Rotllan; Juan F Aranda; Carlos Fernández-Hernando
Journal:  Curr Atheroscler Rep       Date:  2013-05       Impact factor: 5.113

9.  Ion-current-based proteomic profiling of the retina in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Chengjian Tu; Jun Li; Xiaosheng Jiang; Lowell G Sheflin; Bruce A Pfeffer; Matthew Behringer; Steven J Fliesler; Jun Qu
Journal:  Mol Cell Proteomics       Date:  2013-08-26       Impact factor: 5.911

Review 10.  Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy.

Authors:  Isabella Giacomini; Federico Gianfanti; Maria Andrea Desbats; Genny Orso; Massimiliano Berretta; Tommaso Prayer-Galetti; Eugenio Ragazzi; Veronica Cocetta
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.